{"id":"https://openalex.org/W4281695385","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.606","title":"Does race influence long-term outcomes after neoadjuvant chemotherapy in breast cancer: A National Cancer Database analysis.","display_name":"Does race influence long-term outcomes after neoadjuvant chemotherapy in breast cancer: A National Cancer Database analysis.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281695385","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.606"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.606","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.606","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.606","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032765285","display_name":"Arya Mariam Roy","orcid":"https://orcid.org/0000-0003-2509-312X","observed_orcids":["https://orcid.org/0000-0003-2509-312X"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arya Mariam Roy","raw_affiliation_strings":["Roswell Park Cancer Institute, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Institute, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036959689","display_name":"Changchuan Jiang","orcid":"https://orcid.org/0000-0002-7392-4154","observed_orcids":["https://orcid.org/0000-0002-7392-4154"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Changchuan Jiang","raw_affiliation_strings":["Yale University, New Haven, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University, New Haven, NY;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030647280","display_name":"Song Yao","orcid":"https://orcid.org/0000-0001-9442-1313","observed_orcids":["https://orcid.org/0000-0001-9442-1313"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Song Yao","raw_affiliation_strings":["Roswell Park Comprehensive Cancer Center, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Comprehensive Cancer Center, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013007356","display_name":"Stuthi Pavani Perimbeti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stuthi Perimbeti","raw_affiliation_strings":["Roswell Park Comprehensive Cancer Center, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Comprehensive Cancer Center, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064151962","display_name":"Shipra Gandhi","orcid":"https://orcid.org/0000-0003-3506-0284","observed_orcids":["https://orcid.org/0000-0003-3506-0284"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shipra Gandhi","raw_affiliation_strings":["Roswell Park Comprehensive Cancer Center, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Comprehensive Cancer Center, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"606","last_page":"606"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10556","display_name":"Global Cancer Incidence and Screening","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.859000027179718},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9769999980926514},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9309999942779541},{"id":"https://openalex.org/keywords/racial-disparities","display_name":"racial disparities","score":0.8939999938011169},{"id":"https://openalex.org/keywords/black-patients","display_name":"Black patients","score":0.8119999766349792},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.875},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8980000019073486},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9860000014305115},{"id":"https://openalex.org/keywords/hr-her2-breast-cancer","display_name":"hormone receptor-positive HER2-negative breast cancer","score":0.9079999923706055},{"id":"https://openalex.org/keywords/residual-disease","display_name":"residual disease","score":0.7570000290870667},{"id":"https://openalex.org/keywords/long-term-outcomes","display_name":"long-term outcomes","score":0.7450000047683716},{"id":"https://openalex.org/keywords/national-cancer-database","display_name":"National Cancer Database","score":0.6620000004768372},{"id":"https://openalex.org/keywords/cancer-care-disparities","display_name":"cancer care disparities","score":0.578000009059906},{"id":"https://openalex.org/keywords/insurance-status","display_name":"insurance status","score":0.4429999887943268},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.9179999828338623},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.906000018119812},{"id":"https://openalex.org/keywords/health-care-access","display_name":"health care access","score":0.3019999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9131861925125122},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7251788377761841},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6715143322944641},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.6119129657745361},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.607157826423645},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5643486976623535},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5548829436302185},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5104061961174011},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4679946303367615},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4578898847103119},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4478783905506134},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.606","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.606","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.606","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"},{"score":0.7578999996185303,"id":"https://metadata.un.org/sdg/10","display_name":"Reduced inequalities"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4396590485","https://openalex.org/W7160278428","https://openalex.org/W3107164600","https://openalex.org/W4313891355","https://openalex.org/W4412201583","https://openalex.org/W4411290007","https://openalex.org/W4361270177","https://openalex.org/W4205530579","https://openalex.org/W4392122857","https://openalex.org/W4205778468"],"abstract_inverted_index":{"606":[0],"Background:":[1],"Pathologic":[2],"complete":[3],"response":[4],"(pCR)":[5],"after":[6,56,378],"neoadjuvant":[7],"chemotherapy":[8],"(NACT)":[9],"is":[10],"a":[11,124,182],"surrogate":[12],"predictor":[13],"for":[14,69,103,121,427],"long-term":[15],"survival":[16,30],"in":[17,44,213,268,288,301,321,400,404],"breast":[18,154],"cancer":[19,155],"(BC).":[20],"Patients":[21],"who":[22,50,83,257],"attain":[23,387],"pCR":[24,43,58,188,375],"have":[25],"improved":[26],"relapse-free":[27],"and":[28,46,53,59,71,93,115,123,138,170,320,350,411],"overall":[29],"(OS)":[31],"when":[32,264],"compared":[33,189,265,305],"to":[34,90,98,190,266,306,373,421],"patients":[35,49,141,367,382,414],"with":[36,74,101,295,368,383,415],"residual":[37],"disease":[38],"(RD).":[39],"We":[40],"examined":[41],"the":[42,78,302,419],"Black":[45,70,139,149,365,381,428],"White":[47,72,137],"BC":[48,76,140,366,406],"received":[51,84],"NACT":[52],"their":[54],"OS":[55,263,300,393,401],"attaining":[57,187],"RD.":[60,416],"Methods:":[61],"The":[62,209,396],"National":[63],"Cancer":[64],"Database":[65],"(NCDB)":[66],"was":[67,88,119,129,211,402],"queried":[68],"females":[73],"non-metastatic":[75],"from":[77],"years":[79],"2010":[80],"\u2013":[81],"2016":[82],"NACT.":[85,379],"Logistic":[86],"regression":[87,97],"used":[89,120],"analyze":[91,99],"pCR/RD":[92],"Cox":[94],"proportional":[95],"hazards":[96],"OS,":[100],"adjustment":[102],"age,":[104],"race,":[105],"stage,":[106],"grade,":[107],"body":[108],"mass":[109],"index,":[110],"treatments":[111],"received,":[112],"insurance":[113],"status":[114],"comorbidities.":[116],"STATA/IC":[117],"16.0":[118],"analysis":[122],"two-sided":[125],"p-value":[126],"<":[127,227,253,318,335,348,362],"0.05":[128],"considered":[130],"significant.":[131],"Results:":[132],"A":[133],"total":[134],"of":[135,186],"101,014":[136],"were":[142,370],"identified,":[143],"including":[144],"24,852":[145],"(Whites":[146,158,172],"-":[147,150,159,162,173,176,204,224,237,250,281,315,332,345,359,408],"74.43%,":[148],"25.57%)":[151],"triple":[152],"negative":[153,168],"(TNBC),":[156],"51,043":[157],"84%,":[160],"Blacks":[161,175,191,260,297],"16%)":[163],"hormone":[164],"receptor":[165],"positive":[166],"HER2":[167,178],"(HR+HER2-)":[169],"17,818":[171],"83%,":[174],"17%)":[177],"positive.":[179],"Whites":[180,267,307,377],"had":[181,261,298,391],"slightly":[183],"higher":[184],"odds":[185],"(adjusted":[192,271],"Odds":[193],"Ratio":[194,273],"(aOR)":[195],"=":[196,202,207,218,222,231,235,240,244,248,275,279,284,309,313,326,330,339,343,353,357],"1.040,":[197],"95%":[198,220,233,246,277,311,328,341,355],"Confidence":[199],"Interval":[200],"(CI)":[201],"1.02":[203,236],"1.19,":[205],"p":[206,226,239,252,283,317,334,347,361],"0.02).":[208],"difference":[210,399],"largest":[212],"TNBC":[214,289,324,369],"subtype":[215,270,385],"(TNBC:":[216],"aOR":[217,230,243],"1.34,":[219],"CI":[221,234,247,278,312,329,342,356],"1.20":[223],"1.56,":[225],"0.001;":[228],"HR+HER2-:":[229],"1.1;":[232],"1.32,":[238],"0.038;":[241],"HER2+:":[242],"1.13,":[245],"1.08":[249],"1.27,":[251],"0.001).":[254,363],"Among":[255,293],"those":[256,294],"attained":[258],"pCR,":[259,388],"worse":[262,299,392],"HER2+":[269,351,384,412],"Hazard":[272],"(aHR)":[274],"1.41,":[276],"1.04":[280],"1.93,":[282],"0.028)":[285],"but":[286],"not":[287],"or":[290],"HR+HER2-":[291,337,410],"subtypes.":[292],"RD,":[296],"whole":[303],"cohort":[304],"(aHR":[308,325,338,352],"1.43,":[310],"1.26":[314],"1.58,":[316],"0.001),":[319,336],"all":[322,405],"subtypes:":[323],"1.17,":[327],"1.11":[331],"1.23,":[333],"1.38,":[340],"1.31":[344],"1.45,":[346,354],"0.001)":[349],"1.32":[358],"1.59,":[360],"Conclusions:":[364],"less":[371],"likely":[372],"achieve":[374],"than":[376,394],"When":[380],"did":[386],"they":[389],"still":[390],"Whites.":[395],"same":[397],"racial":[398],"observed":[403],"subtypes":[407],"TNBC,":[409],"among":[413],"This":[417],"highlights":[418],"importance":[420],"investigate":[422],"novel":[423],"personalized":[424],"treatment":[425],"strategies":[426],"patients.":[429]},"counts_by_year":[{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2022-06-13T00:00:00"}